DNA methylation and autoimmune disease.
暂无分享,去创建一个
[1] S. Hanash,et al. DNA Methylation and Chromatin Structure Regulate T Cell Perforin Gene Expression1 , 2003, The Journal of Immunology.
[2] Zhiyong Zhang,et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. , 2003, Arthritis & Rheumatism.
[3] W. Mccune,et al. The Apoptotic Ligands TRAIL, TWEAK, and Fas Ligand Mediate Monocyte Death Induced by Autologous Lupus T Cells1 , 2002, The Journal of Immunology.
[4] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[5] S. Santangelo,et al. DNA Methylation Changes at Human Th2 Cytokine Genes Coincide with DNase I Hypersensitive Site Formation During CD4+ T Cell Differentiation1 , 2002, The Journal of Immunology.
[6] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[7] B. Richardson,et al. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. , 2002, The Journal of nutrition.
[8] D. Gutsch,et al. Effect of DNA methylation and chromatin structure on ITGAL expression , 2002 .
[9] A. Perl,et al. Abnormal T cell signal transduction in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[10] Suneet Agarwal,et al. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. , 2002, Immunity.
[11] D. Gutsch,et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[12] R. Yung,et al. DNA methylation and the regulation of gene transcription , 2002, Cellular and Molecular Life Sciences CMLS.
[13] Peter A. Jones. DNA methylation and cancer , 2002, Oncogene.
[14] S. Piantadosi,et al. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. , 2001, Cancer research.
[15] M. Kaplan,et al. Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies , 2001, Lupus.
[16] A. Rosen,et al. Clearing the way to mechanisms of autoimmunity , 2001, Nature Medicine.
[17] S. Hanash,et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. , 2001, Arthritis and rheumatism.
[18] L. Beretta,et al. LFA-1 overexpression and T cell autoreactivity: mechanisms. , 2000, Immunological investigations.
[19] M. Walport. Lupus, DNase and defective disposal of cellular debris , 2000, Nature Genetics.
[20] M. Kaplan,et al. TRAIL (Apo2 Ligand) and TWEAK (Apo3 Ligand) Mediate CD4+ T Cell Killing of Antigen-Presenting Macrophages1 , 2000, The Journal of Immunology.
[21] B. Richardson,et al. Role of DNA methylation in the regulation of cell function. , 1999, The Journal of laboratory and clinical medicine.
[22] P. Butler,et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity , 1999, Nature Medicine.
[23] Chyung-Ru Wang,et al. Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.
[24] D. Mevorach,et al. Systemic Exposure to Irradiated Apoptotic Cells Induces Autoantibody Production , 1998, The Journal of experimental medicine.
[25] L. E. McDonald,et al. Distinct Methylation of the Interferon γ (IFN-γ) and Interleukin 3 (IL-3) Genes in Newly Activated Primary CD8+ T Lymphocytes: Regional IFN-γ Promoter Demethylation and mRNA Expression Are Heritable in CD44highCD8+ T Cells , 1998, The Journal of experimental medicine.
[26] B. Richardson,et al. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. , 1997, Arthritis and rheumatism.
[27] R. Yung,et al. Mechanisms of drug-induced lupus. III. Sex-specific differences in T cell homing may explain increased disease severity in female mice. , 1997, Arthritis and rheumatism.
[28] S. Shichijo,et al. Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5‐Aza‐2′‐deoxycytidine , 1996, Japanese journal of cancer research : Gann.
[29] E. Amento,et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. , 1996, The Journal of clinical investigation.
[30] R. Herrera,et al. Adhesion through the Interaction of Lymphocyte Function-associated Antigen-1 with Intracellular Adhesion Molecule-1 Induces Tyrosine Phosphorylation of p130 and Its Association with c-CrkII (*) , 1996, The Journal of Biological Chemistry.
[31] C. Morimoto,et al. CD27-CD70 interactions regulate B-cell activation by T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] B. Richardson,et al. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. , 1995, Journal of immunology.
[33] N. Lalwani,et al. Fas ligation triggers apoptosis in macrophages but not endothelial cells , 1994, European journal of immunology.
[34] S. Clark,et al. High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.
[35] K. O'rourke,et al. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. , 1994, Arthritis and rheumatism.
[36] T. Takeuchi,et al. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. , 1993, The Journal of clinical investigation.
[37] E. Amento,et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. , 1993, The Journal of clinical investigation.
[38] B. Richardson,et al. Evidence that macrophages are programmed to die after activating autologous, cloned, antigen‐specific, CD4+ T cells , 1993, European journal of immunology.
[39] S. Hanash,et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. , 1992, Arthritis and rheumatism.
[40] B. Richardson,et al. Procainamide inhibits DNA methyltransferase in a human T cell line. , 1991, The Journal of rheumatology.
[41] S Hanash,et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. , 1990, Arthritis and rheumatism.
[42] J. Hudson,et al. CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation. , 1990, Clinical immunology and immunopathology.
[43] J. Trowsdale,et al. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells , 1989, Nature.
[44] R. Coffman,et al. Heterogeneity of cytokine secretion patterns and functions of helper T cells. , 1989, Advances in immunology.
[45] S. Hanash,et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. , 1988, Journal of immunology.
[46] R. Coffman,et al. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. , 1988, Journal of immunology.
[47] J. Hudson,et al. Increased immunoglobulin response to gamma-interferon by lymphocytes from patients with systemic lupus erythematosus. , 1988, Clinical immunology and immunopathology.
[48] B. Leyland-Jones,et al. Biochemistry of azacitidine: a review. , 1987, Cancer treatment reports.
[49] M. Sneller,et al. DNA methylation alters chromatin structure and regulates Thy-1 expression in EL-4 T cells. , 1987, Journal of immunology.
[50] B. Richardson,et al. Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. , 1986, Human immunology.
[51] S. Pals,et al. Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction. , 1985, Journal of immunology.
[52] T. Hirano,et al. Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells. , 1985, Journal of immunology.
[53] T. Waldmann,et al. Activators of protein kinase C and 5‐azacytidine induce IL‐2 receptor expression on human T lymphocytes , 1985, Journal of cellular biochemistry.
[54] Z. Ballas. The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma. , 1984, Journal of immunology.
[55] P. Jones,et al. Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA. , 1982, Journal of molecular biology.
[56] E. Gleichmann,et al. Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E , 1982, The Journal of experimental medicine.
[57] R. Palmiter,et al. DNA methylation controls the inducibility of the mouse metallothionein-I gene in lymphoid cells , 1981, Cell.